DOI: 10.1093/ofid/ofad665 ISSN: 2328-8957
Breaking Barriers: A Single Center Real World Experience with Recruitment and Administration of COVID-19 Monoclonal Antibodies and Opportunities for Improvement
Sara Brenner, Alexander Knee, Douglas Salvador, Erica Housman, Gladys Fernandez, Armando Paez- Infectious Diseases
- Oncology
Abstract
We conducted a retrospective exploratory study evaluating factors associated with selection to receive and infusion with COVID-19 monoclonal antibodies (mAb). While priority was given to high-risk patients, patients with increased social vulnerability index (SVI) were less likely to present for infusion, raising concern that social factors created barriers to treatment.